Caplin Point Laboratories Ltd.

CAPLIPOINT

₹1888.6

0.04% (0.7)

Market Cap

₹14,329 Cr.

P/E

27.81

About

Caplin Point Laboratories was established in 1990 to manufacture a range of ointments, creams and other external applications. It is the mid-sized company in India’s pharmaceutical sector to be engage… Read more

Caplin Point Laboratories was established in 1990 to manufacture a range of ointments, creams … Read more

Low

1221

52W Range

High

2636

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

Share price

Share price has increased over last 10 years due to earnings
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
ROE

Roe has decreased vs 10 year trend
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Distribution Channel

Manufacturing Break-Up

Operational Metrics

Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Caplin Point Laboratories Ltd. Business

What does Caplin Point Lab do?

Established in 1990, Caplin Point Laboratories is a mid-sized company in India manufacturing APIs, finished formulations, and engaging in research & development, clinical research, and global marketing.

Who are the competitors of Caplin Point Lab?

Caplin Point Lab major competitors are Gufic Biosciences, Gland Pharma, Jubilant Pharmova, Sanofi India, Natco Pharma, Alembic Pharma, Marksans Pharma.
Market Cap of Caplin Point Lab is ₹14,350 Crs.
While the median market cap of its peers are ₹14,820 Crs.

Is Caplin Point Lab financially stable compared to its competitors?

Caplin Point Lab seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Strong fundamentals With FII/DII buying And Retail selling

Fundamentally strong companies which are in favour with 'smart money' and going out of favour with retail.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep Dec	Mar Jun Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec	Mar Sep Dec				Dec
Investor Presentation		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Dec	Dec
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep	Mar Jun	Mar Jun Sep Dec	Sep	Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Caplin Point Laboratories Ltd.

Analysis: Caplin Point Laboratories - Dr Vijay Malik

View the discussion on ValuePickr

Data Backed Look At Caplin Steriles - Chins

Accounting Issues In Caplin Point - ValuePickr

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Caplin Point Laboratories Ltd.